Knott David M Jr - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Knott David M Jr ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$248
-42.9%
140,9210.0%0.10%
-42.1%
Q1 2023$434
-51.5%
140,921
-16.5%
0.17%
-49.4%
Q4 2022$895
-99.8%
168,839
+11.6%
0.34%
+50.2%
Q3 2022$534,000
+301.5%
151,286
+673.2%
0.22%
+400.0%
Q4 2021$133,00019,5660.04%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders